A retrospective analysis of 12 cases of primary thyroid lymphoma

  • Yang ZHANG ,
  • Ji-xin ZHANG ,
  • Jian SHI ,
  • Nan YU ,
  • Zhen-fang YUAN ,
  • Gui-zhi LU ,
  • Ying GAO ,
  • Yan-ming GAO ,
  • Xiao-hui GUO
Expand
  • 1. Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
    2. Department of Pathology,Peking University First Hospital, Beijing 100034, China
    3. Department of Ultrasound, Peking University First Hospital, Beijing 100034, China

Received date: 2017-11-17

  Online published: 2019-02-26

Supported by

Supported by Capital Foundation of Medical Developments(2018-4-4077);and Thyroid Research Program of Young and Middle-aged Physicians from China International Medical Foundation(2017N14)

Abstract

Objective: To discuss the clinical characteristics and diagnostic and therapeutic considerations of primary thyroid lymphoma (PTL) by reviewing PTL cases. Methods: In the study, 12 cases of PTL diagnosed and treated in Peking University First Hospital between January 1995 and September 2015 were identified. The clinical characteristics, management experiences and prognosis of these cases were reviewed retrospectively. Results: A total of 12 PTL patients (four males and eight females) were collected, with an average age of 63 years (42 to 81 years) at the time of diagnosis. The average time to clarify diagnosis was 5 months (0.5 to 24 months). Eleven patients presented with a rapidly growing neck mass and visited surgical department, except one complained of coughing and suffocated. Seven patients were hypothyroid, and four were euthyroid at the time of diagnosis. In sonography of 11 cases, nine showed bilateral nodules, with an average diameter of 3.87 cm. Pathologic diagnosis of non-Hodgkin’s lymphoma was confirmed in all the 12 cases by means of partial thyroidectomy (four) or core needle biopsy (eight). The pathological subtypes were diffuse large B cell lymphoma in nine patients, mucosa-associated lymphoid tissue lymphoma (MALToma) in two, and small B cell lymphoma in the other one patient. Five patients were concomitant with Hashimoto’s thyroiditis. Eleven patients received chemotherapy. Only one patient did not have any further treatment after operation due to an inertia type of tumor. The median overall survival time was 24 months (1-117 months), three patients died. Among the patients who survived, seven completed chemotherapy without disease progression, one MALToma case did not receive chemotherapy after thyroidectomy but was still alive with PTL, and one patient just finished his second course of chemotherapy. Conclusion: The diagnosis of PTL should be considered when dealing with rapidly growing goiters in elder female Hashimoto’s thyroiditis patients whose B ultrasound indicates hypoechogenicity in thyroid nodules or parenchyma, especially with lymphadenopathy and tracheal compressions. Timely use of coreneedle biopsy on suspicious cases can avoid unnecessary surgical trauma, and chemotherapy is the main treatment.

Cite this article

Yang ZHANG , Ji-xin ZHANG , Jian SHI , Nan YU , Zhen-fang YUAN , Gui-zhi LU , Ying GAO , Yan-ming GAO , Xiao-hui GUO . A retrospective analysis of 12 cases of primary thyroid lymphoma[J]. Journal of Peking University(Health Sciences), 2019 , 51(1) : 165 -170 . DOI: 10.19723/j.issn.1671-167X.2019.01.028

References

[1] Stein SA, Wartofsky L . Primary thyroid lymphoma: a clinical review[J]. J Clin Endocrinol Metab, 2013,98(8):3131-3138.
[2] Sarinah B, Hisham AN . Primary lymphoma of the thyroid: diagnostic and therapeutic considerations[J]. Asian J Surg, 2010,33(1):20-24.
[3] Onal C, Li YX, Miller RC , et al. Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study[J]. Ann Oncol, 2011,22(1):156-164.
[4] Mack LA, Pasieka JL . An evidence-based approach to the treatment of thyroid lymphoma[J]. World J Surg, 2007,31(5):978-986.
[5] Alzouebi M, Goepel JR, Horsman JM , et al. Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre[J]. Int J Oncol, 2012,40(6):2075-2080.
[6] Sakorafas GH, Kokkoris P, Farley DR . Primary thyroid lymphoma (correction of lympoma): diagnostic and therapeutic dilemmas[J]. Surg Oncol, 2010,19(4):e124-e129.
[7] 李昌幼, 罗佐杰 . 原发性甲状腺淋巴瘤的发病机制及诊治现状[J]. 实用医学杂志, 2013,2(3):341-342.
[8] Holm LE, Blomgren H, Lowhagen T . Cancer risks in patients with chronic lymphocytic thyroiditis[J]. N Engl J Med, 1985,312(10):601-604.
[9] Noureldine SI, Tufano RP . Association of Hashimoto’s thyroiditis and thyroid cancer[J]. Curr Opin Oncol, 2015,27(1):21-25.
[10] 朱坚, 费健 . 原发性甲状腺淋巴瘤的诊断和治疗分析[J]. 外科理论与实践, 2013,18(2):156-158.
[11] 谢婧, 邓先兆, 樊友本 , 等. 原发性甲状腺淋巴瘤疗效分析[J]. 中国普外基础与临床杂志, 2014,21(9):1097-1101.
[12] Ota H, Ito Y, Matsuzuka F , et al. Usefulness of ultrasonography for diagnosis of malignant lymphoma of the thyroid[J]. Thyroid, 2006,16(10):983-987.
[13] 杨光旭, 彭格红 . 原发性甲状腺淋巴瘤超声表现与病理对比分析[J]. 现代医药卫生, 2017,33(4):566-567.
[14] Yang L, Wang A, Zhang Y , et al. 12 cases of primary thyroid lymphoma in China[J]. J Endocrinol Invest, 2015,38(7):739-744.
[15] 骆惊涛, 魏玺, 张仑 . 原发性甲状腺淋巴瘤的超声表现病理及其他影像学特征分析[J]. 中国肿瘤临床, 2014,41(2):123-126.
[16] 彭晓琼, 蒲大容, 涂波 , 等. 原发性甲状腺恶性淋巴瘤的声像图特征及误诊分析[J]. 重庆医学, 2015,44(16):2260-2262.
[17] 杨盼, 孙映荷, 马步云 , 等. 原发性甲状腺非霍奇金淋巴瘤的超声征象分析[J]. 中国普外基础与临床杂志, 2014,21(9):1092-1096.
[18] 张雨涵, 龚洪翰, 张宁 , 等. 原发甲状腺淋巴瘤的CT诊断与鉴别诊断[J]. 实用放射学杂志, 2014,30(7):1238-1240.
[19] Basu S, Li G, Bural G , et al. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility[J]. Acta Radiol, 2009,50(2):201-204.
[20] Derringer GA, Thompson LD, Frommelt RA , et al. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases[J]. Am J Surg Pathol, 2000,24(5):623-639.
[21] 张秉均, 薛勇敢, 刘洪军 , 等. 20例原发性甲状腺淋巴瘤的临床分析[J]. 解放军医学院学报, 2015,36(5):419-423.
[22] 夏青萍, 卫骆云 . 原发性甲状腺恶性淋巴瘤合并桥本氏甲状腺炎11例诊治分析[J]. 浙江实用医学, 2015,20(5):335-337.
[23] Sangalli G, Serio G, Zampatti C , et al. Fine needle aspirationcytology of primary lymphoma of the thyroid: a report of 17 cases[J]. Cytopathology, 2001,12(4):257-263.
[24] 朱庆莉, 姜玉新, 李文波 , 等. 超声引导组织活检对原发性甲状腺淋巴瘤的诊断价值[J]. 协和医学杂志, 2014,5(1):3-7.
[25] Matsuzuka F, Miyauchi A, Katayama S , et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based onour experience of 119 cases[J]. Thyroid, 1993,3(2):93-99.
[26] Wang SA, Rahemtullah A, Faquin WC , et al. Hodgkin’s lymphoma of the thyroid: a clinicopathologic study of five cases andreview of the literature[J]. Mod Pathol, 2005,18(12):1577-1584.
[27] Pyke CM, Grant CS, Habermann TM , et al. Non-Hodgkin’s lymphoma of the thyroid: is more than biopsynecessary?[J]. World J Surg, 1992,16(4):604-609.
[28] Molina A . A decade of rituximab: improving survival outcomes in non-Hodgkin’s lymphoma[J]. Annu Rev Med, 2008,59:237-250.
[29] Penney SE, Homer JJ . Thyroid lymphoma: acute presentation and long-termoutcome[J]. J Laryngol Otol, 2011,125(12):1256-1262.
[30] Belal AA, Allam A, Kandil A , et al. Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma[J]. Am J Clin Oncol, 2001,24(3):299-305.
Outlines

/